このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

テクノロジーの使用に関する意思決定をサポートするための「テクノロジーを話す」ツール

2026年9月21日 更新者:Clara Berridge、University of Washington

テクノロジーの使用に関する意思決定をサポートするために、「テクノロジーを話す」ダイアディック行動介入の機械的研究

The goal of this research is to educate people about different technologies to support care at home when someone is experiencing memory difficulties. "Let's Talk Tech" is a new tool to educate people about technologies commonly used to support care and monitor safety, and help families talk about their feelings about them to understand each other's perspectives. The goal of this clinical trial is to learn if "Let's Talk Tech" helps people feel more prepared to make decisions about technologies.

Researchers will compare Let's Talk Tech to usual care (no intervention) to see if Let's Talk Tech increases peoples' preparedness and confidence to make decisions about technologies.

All participants will:

  • Use the Let's Talk Tech web application together with their study partner that takes up to an hour or do nothing.
  • Complete two surveys. The second survey will be taken within 2 weeks of the first.

One participant in each pair will also take a 3rd short survey 3 months after the first.

調査の概要

詳細な説明

The goal of this research is to help families understand digital health technology options to support dementia care at home so they can negotiate immediate decisions and future use in an informed way. This is a mechanism-focused trial of Let's Talk Tech (LTT), a single-use, self-administered intervention in the form of a web application. It targets education and interpersonal communication processes to enable informed decision making and planning for technology use that relieves care partners of the burden of making decisions without awareness of the person's preferences. Participants are people living with mild Alzheimer's disease (AD) and AD-related dementias (PLWD) or mild cognitive impairment (MCI) and a care partner. The 120 enrolled dyads (60 per study group) will be randomly assigned to receive either the intervention or usual care control. The intervention is self-administered. All participants will complete measures at baseline and at post-test (2 weeks), and care partners will also complete them 3 months later. Aim 1 will test if LTT compared with usual care improves the hypothesized mechanisms of change that are care partners' technology awareness, understanding, communication satisfaction, and intention to honor the PLWD/MCI's preferences, as well as both care partner- and PLWD/MCI-reported dyadic alignment. Aim 2 will examine if and how those hypothesized mechanisms of change improve the post-test and 3-month primary outcomes of care partner preparedness, decisional conflict, and decision making confidence, and secondary outcomes of PLWD/MCI and care partner sharing of technology preferences beyond the dyad and their confidence that PLWD/MCI's preferences will be honored. Exploratory Aim 3 will examine how, with whom, and for what purpose dyad members share technology preferences and explore factors that vary for those who shared with providers vs. family/friends, with the hope of learning how to expand the reach of this intervention to activate dyads' entire care networks.

研究の種類

介入

入学 (実際)

222

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Washington
      • Seattle、Washington、アメリカ、98105
        • University of Washington

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria for Patients:

  • have mild cognitive impairment (MCI) or mild dementia
  • age 55 or older
  • able to understand and speak English

Inclusion Criteria for Co-participants:

  • be identified by the patient as their primary support person
  • age 18 or older
  • able to understand and speak English
  • able to complete LTT together with their study partner at the same time

Exclusion Criteria:

  • None

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Let's Talk Tech intervention

The intervention group will complete the single use self-administered Let's Talk Tech intervention together as a dyad.

Let's Talk Tech is a self-administered dyadic education and communication tool delivered as a web application to support shared decision making about technology use.

介入なし:Usual care

This control group will receive usual care, which means they will complete no intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Preparedness to make technology decisions
時間枠:baseline, 2-week post-test and 3 months

This is one of the three primary outcomes that are not mechanisms of change variables. Participant rates on a 5-point Likert scale [1="Strongly agree" to 5="Strongly disagree"] how much they agree with the statement that they feel prepared to make decisions about technology use for their study partner.

baseline, 2-week post-test and 3 months
Decisional Conflict Scale
時間枠:baseline, 2-week post-test and 3 months

This is one of the three primary outcomes that are not mechanisms of change variables. The Decisional Conflict Scale is a 16-item scale with 5 response categories [0= "Strongly agree" to 4="Strongly disagree"]. Higher scores reflect higher decisional conflict in decision making.

baseline, 2-week post-test and 3 months
Decision Making Confidence Scale (adapted)
時間枠:baseline, 2-week post-test and 3 months

This is one of the three primary outcomes that are not mechanisms of change variables. This is a six-item scale with 5 response categories [0="Not confident at all" to 4= "Very confident"]. Higher scores reflect higher confidence in decision making.

baseline, 2-week post-test and 3 months
Technology awareness
時間枠:baseline and 2-week post-test

Participant rates on a 5-point Likert scale [1="Very aware" to 5="Very unaware"] how aware they are about technologies available to support their partner's care and safety.

baseline and 2-week post-test
Technology understanding
時間枠:baseline and 2-week post-test

4 items assess perceived understanding of each of 4 technologies featured in the intervention [1="Not at all" to 5="Completely"].

baseline and 2-week post-test
Perception of PLWD/MCI's technology understanding
時間枠:baseline and 2-week post-test

4 items assess care partner's perception of how well their study partner understands of each of 4 technologies featured in the intervention [1="Not at all" to 5="Completely"].

baseline and 2-week post-test
Satisfaction with dyadic communication about technology
時間枠:baseline and 2-week post-test

Participant rates on a 5-point Likert scale [1="Very satisfied" to 5="Very dissatisfied"] how satisfied they are with their discussion with their study partner about using technology to support their care or safety.

baseline and 2-week post-test
Intention to honor preferences
時間枠:baseline and 2-week post-test

Participant rates on a 5-point Likert scale [1="Very likely" to 5="Very unlikely"] how likely they are to honor their partner's preferences for how technology is used in their care.

baseline and 2-week post-test
Dyadic alignment about technology use
時間枠:baseline and 2-week post-test

Participant is asked how much they agree with their partner about using technologies to support their care [1="Not at all" to 5="Completely"].

baseline and 2-week post-test
Had conversation about technology
時間枠:baseline and 2-week post-test

Participant answers yes, no or unsure if they've ever had a conversation with their study partner about technology to support care or safety.

baseline and 2-week post-test

二次結果の測定

結果測定
メジャーの説明
時間枠
Shared technology preferences
時間枠:baseline, 2-week post-test and 3 months

Participant answer yes or no if they have ever shared the PLWD/MCI's preferences about technologies to support their care with anyone else.

baseline, 2-week post-test and 3 months
Confidence preferences will be honored
時間枠:baseline, 2-week post-test and 3 months

Participant rates on a 5-point Likert scale [1=Strongly agree to 5=Strongly disagree] about their belief the PLWD/MCI's choices about these technologies will be honored.

baseline, 2-week post-test and 3 months
Satisfaction with involvement of primary participant in technology use decisions
時間枠:baseline, 2-week post-test and 3 months

Participant rates on a 5-point Likert scale [1="Very satisfied" to 5="Very dissatisfied"] how satisfied they are with how involved the primary participant is in decisions about technology to support their care.

baseline, 2-week post-test and 3 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Clara Berridge, PhD、University of Washington

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年2月7日

一次修了 (実際)

2026年8月25日

研究の完了 (実際)

2026年8月25日

試験登録日

最初に提出

2025年1月3日

QC基準を満たした最初の提出物

2025年2月7日

最初の投稿 (実際)

2025年2月10日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月25日

QC基準を満たした最後の更新が送信されました

2026年9月21日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する